• Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=21565982).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gly (c.742C>G); ClinVar=VCV000376652; Zygosity=Heterozygous (PubMed=21565982; PubMed=32133047).
  

PubMed=21565982; DOI=10.1158/1078-0432.CCR-10-1820; PMCID=PMC3131419
Nardiello T., Jungbluth A.A., Mei A.H.-C., Di Liberto M., Huang X.-G., Dabrowski A., Andrade V.C.C., Wasserstrum R., Ely S., Niesvizky R., Pearse R., Coleman M., Jayabalan D.S., Bhardwaj N., Old L.J., Chen-Kiang S., Cho H.J.
MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
Clin. Cancer Res. 17:4309-4319(2011)

PubMed=32133047; DOI=10.18632/oncotarget.27488; PMCID=PMC7041939
Mei A.H.-C., Tung K., Han J., Perumal D., Lagana A., Keats J.J., Auclair D., Chari A., Jagannath S., Parekh S., Cho H.J.
MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21(Cip1).
Oncotarget 11:727-739(2020)